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Deviations from the normal composition of the airway microbiota have been proposed to influence 
Chronic Obstructive Pulmonary Disease (COPD) but this has not been thoroughly explored and their 
clinical implications are still unclear. 
We aimed at exploring saliva’s microbiota of patients with COPD and its relation with specific clinical 
parameters. 
Experimental design: Sociodemographic, anthropometric, clinical data and saliva samples were collected 
from patients with COPD and healthy individuals. Saliva’s microbiota was characterized by 16S rRNA 
sequencing and analysed using Qiime2 pipeline. 
Results: 38 patients (33♂, 66±8y, FEV1pp 33±7, GOLD III-26, IV-12) and 38 healthy controls (33♂, 66±9y, 
FEV1pp 103±18) participated. Saliva’s microbiota was significantly enriched in Proteobacteria (with higher 
representation of Neisseria and Haemophilus) and less diverse in COPD than in healthy individuals. 
Furthermore, loss of microbiota’s diversity correlated with disease severity. 
Microbiota revealed two major clusters: Patient I, comprising 25% of the patients and a larger cluster 
including the remaining individuals. Additionally, two clusters emerged from the second cluster, Patient 
II (enriched in patients), and Healthy (10 healthy individuals). 
Microbiota diversity was not different between these latter clusters but was significantly decreased in 
Patient I. Proteobacteria was particularly abundant in Patient I and II and depleted in Healthy, whereas 
Bacteroidetes showed the opposite trend. Patient I was enriched in more severe, symptomatic and older 
patients. 
These findings support a close association between the microbiota and COPD and open new avenues to 
promote remodelling of patients’ dysbiotic microbiotas aiming at symptom improvement and preventing 
disease decline. 
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